Atara Biotherapeutics, Inc. (ATRA)
4.18
-0.06
(-1.42%)
USD |
NASDAQ |
Feb 20, 16:00
4.17
-0.01
(-0.24%)
After-Hours: 20:00
Atara Biotherapeutics Total Liabilities (Quarterly) : 66.80M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 4.236B |
| Pfizer Inc. | -- |
| Vertex Pharmaceuticals, Inc. | 7.477B |
| AbbVie, Inc. | 137.19B |
| ACADIA Pharmaceuticals, Inc. | 413.50M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 30.17M |
| Shareholders Equity (Quarterly) | -36.63M |
| Debt to Equity Ratio | -1.600 |
| Current Ratio | 1.021 |
| Net Debt Paydown Yield | 6.05% |